Skip to main content
Go to the home page of the European Commission (opens in new window)
English en
CORDIS - EU research results
CORDIS

Understanding Serotonergic Regulation of Working Memory

Project description

Why many psychiatric treatments can’t improve cognitive abilities

What is the role of serotonin (5-HT) in the regulation of inhibition in cortical activity and the consequences in influencing working memory (WM) maintenance? Currently available treatments targeting 5-HT signalling address different mental health symptoms but typically not cognitive capabilities. The EU-funded SERWOM project will image the electrical activities of pyramidal and distinct GABAergic interneurons while well-trained mice execute a delayed two-alternative forced choice task to read out WM during the delay period. Imaging will record cortical activity at the mesoscopic (cortex-wide) and local (prefrontal cortex) levels. The project will use a mouse model of schizophrenia that is known to exhibit WM deficits to correlate possible alterations in 5-HT signalling during cellular-level WM maintenance with WM performance at the behavioural level.

Objective

Functional integrity of the prefrontal cortex (PFC) is essential for higher ‘executive’ functions such as working memory (WM). Serotonin (5-HT) modulates GABAergic neurotransmission in the PFC through different 5-HT receptor subtypes that are selectively expressed in distinct GABAergic cell types. Altered GABAergic neurotransmission in the PFC of patients suffering from schizophrenia and depression is believed to be central to their pathophysiology. Currently available treatments targeting 5-HT signaling have addressed different mental health symptoms but typically not cognitive capabilities. Therefore, characterizing the causal role of distinct GABAergic cell types on circuit activity is a critical step in understanding the circuit mechanism of WM.
This proposal focuses on the role of 5-HT in the regulation of inhibition in cortical activity and their consequences in influencing WM maintenance. I will simultaneously image the electrical activities of pyramidal and distinct GABAergic interneurons while well-trained mice execute a delayed two alternative forced choice (2AFC) task to read out WM during the delay period. Imaging will be performed in both wide-field and two-photon imaging mode to record cortical activity at the mesoscopic (cortex-wide) and local (PFC) levels, respectively. I will combine optical imaging with optogenetic stimulation/silencing to manipulate GABAergic interneurons in the PFC and serotonin release in the dorsal raphe (DR) during the execution of the 2AFC task. Additionally, I will use a mouse model of schizophrenia that is known to exhibit WM deficits to correlate possible alterations in serotonin signaling during cellular-level WM maintenance with WM performance at the behavioral level. This could allow us to understand why many psychiatric treatments are mostly ineffective at improving cognitive abilities and how modulation of the serotonergic system could reverse these effects, ultimately helping to develop new therapeutic treatments.

Fields of science (EuroSciVoc)

Keywords

Programme(s)

Topic(s)

Funding Scheme

MSCA-IF - Marie Skłodowska-Curie Individual Fellowships (IF)

See all projects funded under this funding scheme

Call for proposal

(opens in new window) H2020-MSCA-IF-2019

See all projects funded under this call

Coordinator

THE FRANCIS CRICK INSTITUTE LIMITED
Net EU contribution
€ 186 317,04
Address
1 MIDLAND ROAD
NW1 1AT London
United Kingdom
Region
London Inner London — West Camden and City of London
Activity type
Research Organisations
Links
Total cost
€ 186 317,04

Participants (1)